LivaNova PLC is a medical devices business based in the US. LivaNova shares (LIVN) are listed on the NASDAQ and all prices are listed in US Dollars. LivaNova employs 4,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in LivaNova
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LIVN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
LivaNova stock price (NASDAQ: LIVN)Use our graph to track the performance of LIVN stocks over time.
LivaNova shares at a glance
|Latest market close||$83.54|
|52-week range||$41.07 - $90.25|
|50-day moving average||$82.63|
|200-day moving average||$78.04|
|Wall St. target price||$95.17|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-5.41|
Buy LivaNova shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy LivaNova stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
LivaNova price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||0.58%|
|3 months (2021-04-30)||-1.57%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Is LivaNova under- or over-valued?
Valuing LivaNova stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LivaNova's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LivaNova's PEG ratio
LivaNova's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.0239. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LivaNova's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
LivaNova's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $46.3 million.
The EBITDA is a measure of a LivaNova's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1 billion|
|Gross profit TTM||$605.3 million|
|Return on assets TTM||-0.34%|
|Return on equity TTM||-31.94%|
|Market capitalisation||$4.2 billion|
TTM: trailing 12 months
Shorting LivaNova shares
There are currently 2.1 million LivaNova shares held short by investors – that's known as LivaNova's "short interest". This figure is 13.7% up from 1.9 million last month.
There are a few different ways that this level of interest in shorting LivaNova shares can be evaluated.
LivaNova's "short interest ratio" (SIR)
LivaNova's "short interest ratio" (SIR) is the quantity of LivaNova shares currently shorted divided by the average quantity of LivaNova shares traded daily (recently around 212843.55644356). LivaNova's SIR currently stands at 10.01. In other words for every 100,000 LivaNova shares traded daily on the market, roughly 10010 shares are currently held short.
However LivaNova's short interest can also be evaluated against the total number of LivaNova shares, or, against the total number of tradable LivaNova shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LivaNova's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 LivaNova shares in existence, roughly 40 shares are currently held short) or 0.0436% of the tradable shares (for every 100,000 tradable LivaNova shares, roughly 44 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against LivaNova.
Find out more about how you can short LivaNova stock.
LivaNova share dividends
We're not expecting LivaNova to pay a dividend over the next 12 months.
LivaNova share price volatility
Over the last 12 months, LivaNova's shares have ranged in value from as little as $41.07 up to $90.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LivaNova's is 0.8945. This would suggest that LivaNova's shares are less volatile than average (for this exchange).
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers.
Stocks similar to LivaNova
LivaNova in the news
Interesting LIVN Put And Call Options For December 2022
LivaNova PLC (LIVN) Q2 2021 Earnings Call Transcript
LivaNova's (LIVN) CEO Damien McDonald on Q2 2021 Results - Earnings Call Transcript
Frequently asked questionsWhat percentage of LivaNova is owned by insiders or institutions?
Currently 0.453% of LivaNova shares are held by insiders and 103.25% by institutions. How many people work for LivaNova?
Latest data suggests 4,000 work at LivaNova. When does the fiscal year end for LivaNova?
LivaNova's fiscal year ends in December. Where is LivaNova based?
LivaNova's address is: 20 Eastbourne Terrace, London, United Kingdom, W2 6LG What is LivaNova's ISIN number?
LivaNova's international securities identification number is: GB00BYMT0J19 What is LivaNova's CUSIP number?
LivaNova's Committee on Uniform Securities Identification Procedures number is: G5509L101
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert